Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Drugs - Real World Outcomes|October 18, 2016
Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010-2015)Arianna Waye, Anderson W Chuck
International Journal of Technology Assessment in Health Care|April 11, 2008
Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcersAnderson W Chuck, David Hailey, Philip Jacobs, et al.
Journal of the American Pharmacists Association : Japha|February 29, 2012
Blood pressure kiosks for medication therapy management programs: business opportunity for pharmacistsSherilyn K D Houle, Anderson W Chuck, Ross T Tsuyuki
Vaccine|June 18, 2010
Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccinesAnderson W Chuck, Philip Jacobs, Gregory Tyrrell, et al.
International Journal of Technology Assessment in Health Care|September 20, 2012
Benefits of pharmaceutical innovation: the case of simvastatin in CanadaNguyen Xuan Thanh, Anderson W Chuck, Arto Ohinmaa, et al.
American Journal of Preventive Medicine|July 12, 2008
Cancer screening among the overweight and obese in CanadaRebecca S Mitchell, Raj S Padwal, Anderson W Chuck, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|July 25, 2013
Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysisNguyen Xuan Thanh, Jessica Moffatt, Philip Jacobs, et al.
Pageof 2